Psoriasis treatment has significantly improved since the mid-2000s with the arrival of biologic drugs.Therapies, including TNF-α inhibitors and interleukin inhibitors, have advanced enough to target not only PASI 75 but PASI 90 and PASI 100 in psoriasis treatment.As physicians can prescribe biologic
The quarantine authorities said Wednesday that about 13 million more people would complete their Covid-19 vaccination, helping to attain the goal of immunizing 70 percent of all people this month."We are currently conducting the second jab of the vaccine intensively, and expect that about 13 million
A research team of Yonsei Cancer Center (YCC) and Severance Hospital has reaffirmed the efficacy and safety of atezolizumab combined with etoposide and carboplatin as first-line therapy in small cell lung cancer (SCLC) patients. The research team, led by YCC Professor Hong Min-hee and Professor Lee
“Domestic patients who receive insurance benefits for the treatment of spinal muscular atrophy (SMA) are already symptomatic. However, if symptoms are found, the disease has progressed to some extent, and the damage cannot be recovered even with treatment. Therefore, it is most important to diagnose
AbbVie’s selective and irreversible JAK inhibitor Rinvoq (upadacitinib) expanded indications for psoriatic arthritis, ankylosing spondylitis, and atopic dermatitis, in addition to the existing rheumatoid arthritis.On Tuesday, the Ministry of Food and Drug Safety authorized Rinvoq to treat psoriatic
A domestic research team has presented a new standard to accurately evaluate the possibility of a nipple-areola preserving mastectomy in breast cancer patients.The research team, led by Professors Jeong Joon and Bae Sung-jun of the Surgical Department and Cha Yoon-jin of the Pathology Department at
SK Bioscience has extended its capacity reservation contract with the Coalition for Epidemic Preparedness Innovations (CEPI) to use its L-House plant in Andong, North Gyeongsang Province, to produce Covid-19 vaccines supported by CEPI.Under the accord, three of SK Bioscience's nine L-House productio
A Seoul National University Bundang Hospital (SNUBH) research team has identified the specific genotypes in Koreans that affect the onset of congenital non-progressive night blindness symptoms for the first time.Night blindness refers to the symptom of being unable to discern objects in the dark bec
Humedix has partnered up with a U.S. immuno-oncology developer Kineta to strengthen its CMO business and secure funding for future growth.The company said Tuesday that it has recently decided to sign a strategic investment deal with Kineta, acquiring 1.56 percent of the latter’s Kineta's shares wort
MSD released positive results from a phase 3 study of molnupiravir, an investigational pill to treat Covid-19, drawing attention from the pharmaceutical market.On Tuesday, Kyobo Securities published a monthly report to explain the meaning of the launch of Covid-19 oral treatments.Kim Jeong-hyeon, a
Roche Korea said Tuesday that it would expand the company’s neuroscience unit by receiving approval for its two mental disorder treatments -- Evrysdi (ingredient: risdiplam) and Enspryng (satralizumab) -- in five years.The company also stressed the importance of treating rare diseases, such as spina
The government said Tuesday nine out of 10 adults have received at least one shot of the Covid-19 vaccine, helping the nation to transit to a "live-with-covid" system."Considering that the target of vaccination in Korea so far has been adults over the age of 18, 90 percent of the people eligible for
One of the reasons for vaccine hesitancy is worries about adverse reactions.Some people in Korea have developed various “vaccine detoxification methods,” claiming they remove or reduce the Covid-19 vaccines’ ill effects.These controversial methods include cupping treatment, intentionally bruising th
AbbVie’s JAK inhibitor Rinvoq (upadacitinib) showed a faster therapeutic effect than Sanofi’s Dupixent (dupilumab) in evaluations of body regions (head and neck, trunk, upper limbs, and lower limbs) of patients with moderate to severe atopic dermatitis.On Thursday, AbbVie released the new analysis o
A research team at Seoul National University Bundang Hospital (SNUBH) has confirmed that smoking e-cigarettes increases the risk of cardiovascular disease compared to those who do not smoke.Some smokers quit regular cigarettes and start using e-cigarettes as they believe that the latter has relative
Takeda Korea's oral treatment Ninlaro (ingredient: ixazomib) has won approval from the Ministry of Food and Drug Safety as maintenance therapy for patients with multiple myeloma who did not receive autologous hematopoietic stem cell transplant.Ninlaro became the first domestic oral proteasome inhibi
Celltrion said that it has submitted a marketing authorization application (MAA) of Regkirona, a Covid-19 treatment, to the European Medicines Agency (EMA) last Friday.“The indication target is adult patients 18 years of age or older confirmed with Covid-19 who do not require supplemental oxygen sup
Sudanese Minister of Investment and International Cooperation Al-Hadi Ibrahim and Industry Minister Ibrahim al-Sheikh visited Shinpoong Pharmaceutical last Friday to discuss the company’s role in developing the African country’s pharmaceutical industry.During the visit, the two ministers toured the
Spectrum Pharmaceuticals, a U.S. partner company of Hanmi Pharmaceutical, will hold a Type-A meeting with the FDA to win approval for Rolontis (eflapegrastim), a treatment for neutropenia.Through a Type-A meeting, a company can take the feedback from the FDA and address issues impeding drug approval
The Korean Society for Laboratory Medicine (KSLM) expressed concerns over the increasing number of people purchasing home antibody kits at pharmacies and taking Covid-19 antibody tests.Home antibody tests are inaccurate and ineffective, and they can evaluate neither a person’s immunity against the C